Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05505370 · ClinicalTrials.gov registry record · NA

Case Series With Saneso 3600 Colonoscope

A NA study of Colonic Neoplasms, sponsored by Saneso.

Completed
Registry status
NA
Development phase
40
Enrollment target
5
Study locations

NCT05505370 is a NA study of Colonic Neoplasms that has completed, run by Saneso. The registered enrollment target is 40 participants, below the 1,520-participant average among 14 other Colonic Neoplasms trials with a reported enrollment target (97% lower). The trial reports 5 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05505370, a NA study of Colonic Neoplasms, has completed, sponsored by Saneso.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
5
Study locations

Study Summary

Saneso colonoscope is a novel FDA cleared colonoscope that provides a 360 degree integrated view of the colon. Saneso colonoscope has five cameras and multiple LED lights at the distal head. The objective of the present study is to evaluate clinical success of the Saneso colonoscope in intubation of the terminal ileum and to obtain user feedback with regards to usability characteristics compared to predicate devices.

Conditions Studied

Interventions

  • DEVICE Colonoscopy

Study Locations (5)

West Virginia

  • West Virginia University School of Medicine - Davis Medical Center - Elkins
  • West Virginia University School of Medicine - Reynolds Memorial Hospital - Glendale
  • West Virginia University School of Medicine - Reynolds Memorial Hospital, - Glendale

Ohio

  • Valley Endoscopy Center - Saint Clairsville
  • Wintersville Endoscopy Center, Wintersville - Wintersville

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2022-04-21
Est. Completion 2022-07-31
Phase NA

Sponsor

Saneso

2 total trials

What the Registry Record Tells You About NCT05505370

The ClinicalTrials.gov registry entry for NCT05505370 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,520-participant average among 14 other Colonic Neoplasms trials with a reported enrollment target (97% lower). The listed sponsor is Saneso, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Colonic Neoplasms appearing as the primary indexed condition, and to 1 intervention - of which Colonoscopy is the first listed.

NCT05505370 reports 5 study locations spanning 2 distinct geographic areas - top geographies include West Virginia, Ohio.

Frequently Asked Questions

What is clinical trial NCT05505370 about?

NCT05505370 is a clinical study titled "Case Series With Saneso 3600 Colonoscope". Saneso colonoscope is a novel FDA cleared colonoscope that provides a 360 degree integrated view of the colon. Saneso colonoscope has five cameras and multiple LED lights at the distal head. The objective of the present study is to evaluate clinical success of the Saneso colonoscope in intubation of...

What is the current status of trial NCT05505370?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2022-04-21. Estimated completion is 2022-07-31.

What conditions does trial NCT05505370 study?

This clinical trial studies the following conditions: Colonic Neoplasms.

What interventions are being tested in trial NCT05505370?

The interventions under investigation include: Colonoscopy (DEVICE).

Who is sponsoring clinical trial NCT05505370?

This trial is sponsored by Saneso, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05505370 being conducted?

This trial has 5 study locations across Ohio, West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colonic Neoplasms

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.